-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Jade Biosciences, Maintains $24 Price Target

Benzinga·03/09/2026 12:40:29
Listen to the news
Wedbush analyst Laura Chico reiterates Jade Biosciences (NASDAQ:JBIO) with a Outperform and maintains $24 price target.